<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Hereford Medical Group</h1>
        This is some intro text.

        <h2>Prescribing where Hereford Medical Group is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0904010AY&amp;denomIds=9.4.1&amp;selectedTab=summary">Gluten free/low protein drink</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Foods for special diets</td>
      <td>385</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>14.48</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0904010AYBBAAAA&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia Lattis low protein drink : 8</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1404000N0&amp;denomIds=14.4&amp;selectedTab=summary">Rabies</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Vaccines and antisera</td>
      <td>33</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>9.88</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1404000N0BDABAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Rabipur vacc inj 1ml pre-filled syringes : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803042S0&amp;denomIds=8.3.4&amp;selectedTab=summary">Triptorelin embonate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>49</td>
      <td>Prostate cancer and gonadorelin analogues</td>
      <td>230</td>
      <td>0.21</td>
      <td>0.02</td>
      <td>0.07</td>
      <td>2.54</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803042S0BCAAAB&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Decapeptyl SR 22.5mg inj vials : 49</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0407020H0&amp;denomIds=4.7.2&amp;selectedTab=summary">Dipipanone hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Opioid analgesics</td>
      <td>8263</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>2.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0407020H0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Dipipanone 10mg / Cyclizine 30mg tablets : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0403010T0&amp;denomIds=4.3.1&amp;selectedTab=summary">Mianserin hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Tricyclic and related antidepressant drugs</td>
      <td>6875</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>2.46</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0403010T0AAACAC&amp;denomIds=4.3.1&amp;selectedTab=summary" target="_blank">Mianserin 30mg tablets : 5</a></div></td></tr></tbody></table>

        <h2>Prescribing where Hereford Medical Group is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000&amp;denomIds=13.2.1&amp;selectedTab=summary">Other emollient preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>689</td>
      <td>Emollients</td>
      <td>933</td>
      <td>0.74</td>
      <td>0.89</td>
      <td>0.07</td>
      <td>-2.15</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000AAA6A6&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin 50% / Liquid paraffin 50% ointment : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBCJA8&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno cream : 40</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBICBW&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol 500 lotion : 318</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBJGCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase gel : 103</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBKFA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol cream : 62</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBKKCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum Junior cream : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBJMCB&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno lotion : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBMFCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase emollient shower gel : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000AACACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Isopropyl myristate 15% / Liquid paraffin 15% gel : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBBAAL&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 cream : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBJPCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum cream : 17</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBLACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase Dayleve gel : 12</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBMGCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase emollient wash gel : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBAHAV&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Ultrabase cream : 25</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBAEA3&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Diprobase ointment : 20</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=130201000BBKDA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno Skin Relief moisturising lotion with shea butter : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Antimuscarinic drugs</td>
      <td>78</td>
      <td>0.08</td>
      <td>0.82</td>
      <td>0.36</td>
      <td>-2.08</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1501030G0AAAAAA&amp;denomIds=15.1.3&amp;selectedTab=summary" target="_blank">Glycopyrronium bromide 200micrograms/1ml inj ampoules : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1202010U0&amp;denomIds=12.2.1&amp;selectedTab=summary">Mometasone furoate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>237</td>
      <td>Drugs used in nasal allergy</td>
      <td>2079</td>
      <td>0.11</td>
      <td>0.31</td>
      <td>0.13</td>
      <td>-1.48</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1202010U0AAAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Mometasone 50micrograms/dose nasal spray : 224</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=1202010U0BBAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Nasonex 50micrograms/dose nasal spray : 13</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>579</td>
      <td>Aminosalicylates</td>
      <td>1353</td>
      <td>0.43</td>
      <td>0.64</td>
      <td>0.15</td>
      <td>-1.44</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BBAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 400mg MR gastro-resistant tablets : 60</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BBAFAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 800mg MR gastro-resistant tablets : 95</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 58</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAFAT&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 2g modified-release granules sachets : 31</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAGAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release tablets : 112</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAKAZ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 3g gastro-resistant modified-release gran sachets : 77</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDACAB&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg suppositories : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAAAC&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa Mesalazine 1g/100ml enema : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAGAP&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg gast res MR gran sachets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAANAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g modified-release granules sachets sugar free : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAEAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release granules sachets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAHAU&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1.5g gastro-resistant modified-release gran sachets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAWAW&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAYAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g modified-release tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BCAHBA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 4g modified-release granules sachets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDADAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 2g/59ml enema : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BHAAAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mezavant XL 1200mg tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 12</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAEAK&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g/application foam enema : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 400mg gastro-resistant tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAPAP&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg gast res MR gran sachets sugar free : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0AAAIAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg modified-release tablets : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0105010B0BDAIAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g suppositories : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803041L0&amp;denomIds=8.3.4&amp;selectedTab=summary">Letrozole</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>110</td>
      <td>Breast cancer</td>
      <td>865</td>
      <td>0.13</td>
      <td>0.44</td>
      <td>0.22</td>
      <td>-1.44</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M81026&amp;numIds=0803041L0AAAAAA&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Letrozole 2.5mg tablets : 110</a></div></td></tr></tbody></table>
        <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
        <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
    </div>

</body>

</html>